Richard MD - InVivo Therapeutics CEO and Presidentident

CEO

Richard MD is CEO and Presidentident of InVivo Therapeutics Holdings
Age 66
Phone617 863 5500
Webhttps://www.invivotherapeutics.com

InVivo Therapeutics Management Efficiency

The company has return on total asset (ROA) of (0.5371) % which means that it has lost $0.5371 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.9811) %, meaning that it created substantial loss on money invested by shareholders. InVivo Therapeutics' management efficiency ratios could be used to measure how well InVivo Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.
InVivo Therapeutics Holdings currently holds 949 K in liabilities with Debt to Equity (D/E) ratio of 0.09, which may suggest the company is not taking enough advantage from borrowing. InVivo Therapeutics has a current ratio of 5.53, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about InVivo Therapeutics' use of debt, we should always consider it together with its cash and equity.

Similar Executives

Found 8 records

CEO Age

Jason OkazakiAssembly Biosciences
49
Gareth SheridanNutriband
35
Richard CunninghamAnebulo Pharmaceuticals
54
Mohamed MBALongeveron LLC
63
Mohamed HashadLongeveron LLC
62
Nevan JDRezolute
58
Jason JDAssembly Biosciences
49
Shaun BagaiRenovoRx
48
InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries . The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts. Invivo Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 7 people. InVivo Therapeutics Holdings (NVIV) is traded on NASDAQ Exchange in USA and employs 6 people.

Management Performance

InVivo Therapeutics Leadership Team

Elected by the shareholders, the InVivo Therapeutics' board of directors comprises two types of representatives: InVivo Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of InVivo. The board's role is to monitor InVivo Therapeutics' management team and ensure that shareholders' interests are well served. InVivo Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, InVivo Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
Jerome Gangitano, VP Operations
Joseph MD, CoFounder
Richard Christopher, CFO, Treasurer
Dr Langer, CoFounder Board
MD FACP, Consultant
Heather JD, Chief Counsel
Richard MD, CEO and Presidentident
Richard Toselli, Chief Medical Officer
Joseph Vacanti, CoFounder

InVivo Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is InVivo Therapeutics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Consideration for investing in InVivo Stock

If you are still planning to invest in InVivo Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the InVivo Therapeutics' history and understand the potential risks before investing.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Transaction History
View history of all your transactions and understand their impact on performance